EUVIMEDEUVIMED entdecken
Crossref

MOTS-C AS A MITONUCLEAR INTEGRATOR AND CARDIOMETABOLIC MODULATOR: RECENT ADVANCES, MOLECULAR MECHANISMS, AND TRANSLATIONAL CHALLENGES

Luiz Felippe Mendes Caquetti

INTERNATIONAL BLEST SCIENTIFIC · 01.04.2026 · 2 (06)

DOI: 10.65671/04tkfk56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INTERNATIONAL BLEST SCIENTIFIC, online erschienen am 01.04.2026. Verfasst von Luiz Felippe Mendes Caquetti.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mitochondrial-derived peptide MOTS-c has emerged as an important regulator of metabolic homeostasis and mitonuclear communication, playing a significant role in the pathophysiology of cardiometabolic diseases and aging. This study aimed to critically analyze recent scientific advances regarding MOTS-c, focusing on its molecular mechanisms, physiological implications, and translational potential. This is an integrative review with a qualitative approach and descriptive quantitative elements, based on studies published between 2020 and 2026 in PubMed, Scopus, and Web of Science databases, including experimental studies, systematic reviews, and clinical investigations. The findings indicate that MOTS-c regulates key pathways such as AMPK activation, glucose metabolism, and lipid oxidation, in addition to modulating inflammatory processes and muscle function. Recent evidence has identified specific molecular interactions, including binding to casein kinase 2, enhancing the understanding of its mechanisms of action. However, a discrepancy remains between robust preclinical evidence and limited clinical maturity, characterized by a lack of clinical trials and absence of analytical standardization. It is concluded that MOTS-c presents significant potential as a biomarker and therapeutic agent, although its clinical application depends on methodological advancements and robust validation in human studies.

Zitieren

APA

Caquetti, L. F. M. (2026). MOTS-C AS A MITONUCLEAR INTEGRATOR AND CARDIOMETABOLIC MODULATOR: RECENT ADVANCES, MOLECULAR MECHANISMS, AND TRANSLATIONAL CHALLENGES. INTERNATIONAL BLEST SCIENTIFIC, 2(06). https://doi.org/10.65671/04tkfk56

Vancouver

Caquetti LFM. MOTS-C AS A MITONUCLEAR INTEGRATOR AND CARDIOMETABOLIC MODULATOR: RECENT ADVANCES, MOLECULAR MECHANISMS, AND TRANSLATIONAL CHALLENGES. INTERNATIONAL BLEST SCIENTIFIC. 2026;2(06). doi:10.65671/04tkfk56

BibTeX
@article{Caquetti2026,
  author = {Caquetti, Luiz Felippe Mendes},
  title = {MOTS-C AS A MITONUCLEAR INTEGRATOR AND CARDIOMETABOLIC MODULATOR: RECENT ADVANCES, MOLECULAR MECHANISMS, AND TRANSLATIONAL CHALLENGES},
  journal = {INTERNATIONAL BLEST SCIENTIFIC},
  year = {2026},
  volume = {2},
  number = {06},
  doi = {10.65671/04tkfk56}
}
Kostenlos starten →